Treace Medical Concepts Statistics
Share Statistics
Treace Medical Concepts has 62.30M shares outstanding. The number of shares has increased by 0.88% in one year.
| Shares Outstanding | 62.30M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.17% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 45.56M |
| Failed to Deliver (FTD) Shares | 969 |
| FTD / Avg. Volume | 0.2% |
Short Selling Information
The latest short interest is 2.38M, so 3.81% of the outstanding shares have been sold short.
| Short Interest | 2.38M |
| Short % of Shares Out | 3.81% |
| Short % of Float | 5.22% |
| Short Ratio (days to cover) | 5.67 |
Valuation Ratios
The PE ratio is -15.67 and the forward PE ratio is -10.71.
| PE Ratio | -15.67 |
| Forward PE | -10.71 |
| PS Ratio | 4.15 |
| Forward PS | 2 |
| PB Ratio | 5.62 |
| P/FCF Ratio | -16.85 |
| PEG Ratio | n/a |
Enterprise Valuation
Treace Medical Concepts Inc. has an Enterprise Value (EV) of 833.19M.
| EV / Earnings | -16.82 |
| EV / Sales | 4.45 |
| EV / EBITDA | -21.36 |
| EV / EBIT | -16.2 |
| EV / FCF | -18.1 |
Financial Position
The company has a current ratio of 4.4, with a Debt / Equity ratio of 0.38.
| Current Ratio | 4.4 |
| Quick Ratio | 3.76 |
| Debt / Equity | 0.38 |
| Total Debt / Capitalization | 27.76 |
| Cash Flow / Debt | -0.65 |
| Interest Coverage | -9.95 |
Financial Efficiency
Return on equity (ROE) is -0.36% and return on capital (ROIC) is -24.7%.
| Return on Equity (ROE) | -0.36% |
| Return on Assets (ROA) | -0.2% |
| Return on Capital (ROIC) | -24.7% |
| Revenue Per Employee | 362.63K |
| Profits Per Employee | -95.98K |
| Employee Count | 516 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.2 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -33.39% in the last 52 weeks. The beta is 0.24, so Treace Medical Concepts 's price volatility has been higher than the market average.
| Beta | 0.24 |
| 52-Week Price Change | -33.39% |
| 50-Day Moving Average | 7.19 |
| 200-Day Moving Average | 7.25 |
| Relative Strength Index (RSI) | 60.53 |
| Average Volume (20 Days) | 486.22K |
Income Statement
In the last 12 months, Treace Medical Concepts had revenue of 187.12M and earned -49.53M in profits. Earnings per share was -0.81.
| Revenue | 187.12M |
| Gross Profit | 151.94M |
| Operating Income | -51.43M |
| Net Income | -49.53M |
| EBITDA | -39.01M |
| EBIT | -51.43M |
| Earnings Per Share (EPS) | -0.81 |
Balance Sheet
The company has 12.98M in cash and 70.30M in debt, giving a net cash position of -57.32M.
| Cash & Cash Equivalents | 12.98M |
| Total Debt | 70.30M |
| Net Cash | -57.32M |
| Retained Earnings | -134.25M |
| Total Assets | 212.92M |
| Working Capital | 119.34M |
Cash Flow
In the last 12 months, operating cash flow was -34.58M and capital expenditures -11.46M, giving a free cash flow of -46.03M.
| Operating Cash Flow | -34.58M |
| Capital Expenditures | -11.46M |
| Free Cash Flow | -46.03M |
| FCF Per Share | -0.76 |
Margins
Gross margin is 8.12K%, with operating and profit margins of -2.75K% and -2.65K%.
| Gross Margin | 8.12K% |
| Operating Margin | -2.75K% |
| Pretax Margin | -2.65K% |
| Profit Margin | -2.65K% |
| EBITDA Margin | -20.85% |
| EBIT Margin | -27.48% |
| FCF Margin | -24.6% |
Dividends & Yields
TMCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -10.23% |
| FCF Yield | -9.33% |
Analyst Forecast
The average price target for TMCI is $8, which is 1% higher than the current price. The consensus rating is "Hold".
| Price Target | $8 |
| Price Target Difference | 1% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
Scores
| Altman Z-Score | 1.92 |
| Piotroski F-Score | 2 |